Newest posters
Educational Pee-analytical Cases in Urine Culture EQA Keep Labs Happy
Elina Tuovinen1, Yvonne Björkman1, Kristel Virtanen1, Päivi Suomala2, Jonna Pelanti1, Heidi Berghäll1
Presented at the EQALM Symposium 2023.
Laboratories benefit from directly integrating their LIS to EQA platform
Kristel Virtanen1, Heidi Berghäll1, Jonna Pelanti1
1 Labquality, Helsinki, Finland
Presented at the Euromedlab 2023 congress and EQALM Symposium 2023.
Performance notifications decrease reaction times to EQA reports
Jonna Pelanti1, Heidi Berghäll1, Kristel Virtanen1
1 Labquality, Helsinki, Finland
Presented at the Euromedlab 2023 congress.
EQA scheme highlights needs for continuous monitoring and recommendations for sample transportation using Pneumatic Tube Systems
Heidi Berghäll1, Iida Silvo1, Kristel Virtanen1, Sunga Park2, Niva Sabeshan2, Jonna Pelanti1, Janne Cadamuro3
1 Labquality, Helsinki, Finland
2 Motryx, Halifax, Canada
3 Department of Laboratory Medicine, Paracelsus Medical University, Salzburg, Austria
Presented at the Euromedlab 2023 congress.
Thyroid stimulating hormone and free thyroxine reference intervals for children and the elderly with Siemens Atellica based on patient data
Jonna Pelanti1,2, Outi Itkonen1, Mikko Anttonen1
1 Department of Clinical Chemistry, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
2 Labquality, Helsinki, Finland
Presented at the Euromedlab 2023 congress.
Pilot study introducing a new EQA scheme for Mycobacterium tuberculosis drug resistance
Kristel Virtanen1, Heidi Berghäll1, Jaana Paakkanen1, Silja Mentula2, Jonna Pelanti1
1 Labquality, Helsinki, Finland
2 Finnish Institute for Health and Welfare, Dept. Health Security, Mycobacterial Reference Laboratory, Helsinki, Finland
Presented at the ECCMID 2023 congress.
A Success Story of EQA Development During the Pandemic
Heidi Berghäll, Marsa Järvenpää, Kirstel Virtanen, Jonna Pelanti
Presented at the EQALM Symposium 2022.
Advantages of Using Direct Integration for EQA Result Reporting
Kristel Virtanen, Heidi Berghäll, Jonna Pelanti
Presented at the EQALM Symposium 2022.
TB or not TB - or DR-TB? Introducing a new EQA scheme for Mycobacterium Tuberculosis drug resistance
Heidi Berghäll1, Jaana Paakkanen1, Silja Mentula2, Kristel Virtanen1, Jonna Pelanti1
1Labquality, Helsinki, Finland
2Finnish Institute for Health and Welfare, Dept. Health Security, Mycobacterial Reference Laboratory, Helsinki, Finland
Presented at the EQALM Symposium 2022
Preanalytical EQA for PTS: A Modern Pneumatic Tube System Monitoring Tool for Clinical Laboratories
Heidi Berghäll1, Iida Silvo1, Kristel Virtanen1, Chris Dail2, Jonna Pelanti1
1Labquality, Helsinki, Finland
2Motryx, Halifax, NS, Canada
Won the best poster award voted by the audience at the 6th EFLM Conference on Preanalytical Phase 2022
First results of an international external quality assessment pilot scheme for SARS-CoV-2 antigen detection
Heidi Berghäll1, Marsa Järvenpää1, Matti Waris2, Vesa Mäntynen3, Jonna Pelanti1
1Labquality, Helsinki, Finland
2Department of Virology, University of Turku, Finland
3Nordlab, Oulu, Finland
Presented at the IFCC Virtual Conference on Critical Role of Clinical Laboratories in the Covid-19 Pandemic 2021
The effect of target values on the performance of photometric glucose results in a general clinical chemistry EQA scheme
Jonna Pelanti1, Dalius Vitkus2, Heidi Berghäll1
1Labquality, Helsinki, Finland
2Department of Physiology, Biochemistry, Microbiology and Laboratory Medicine, Vilnius University, Lithuania
Presented at the EQALM Symposium 2019.
Ask for more information
Jonna Pelanti
Heidi Berghäll
